| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology & Reanimatology, Gunma University School of Medicine, Gunma, Japan
Address correspondence and reprint requests to Shigeru Saito, MD, PhD, Department of Anesthesiology & Reanimatology, Gunma University School of Medicine, 3-39-22, Showa-machi, Maebashi, 371-8511, Gunma, Japan. Address e-mail to shigerus{at}showa.gunma-u.ac.jp
Local anesthetics can be neurotoxic. To test the hypothesis that exposure to local anesthetics produces morphological changes in growing neurons and to compare this neurotoxic potential between different local anesthetics, we performed in vitro cell biological experiments with isolated dorsal root ganglion neurons from chick embryos. The effects of lidocaine, bupivacaine, mepivacaine, and ropivacaine were examined microscopically and quantitatively assessed using the growth cone collapse assay. We observed that all local anesthetics produced growth cone collapse and neurite degeneration. However, they showed significant differences in the dose response. The IC50 values were approximately, 10-2.8 M for lidocaine, 10-2.6 M for bupivacaine, 10-1.6 M for mepivacaine, and 10-2.5 M for ropivacaine at 15 min exposure. Some reversibility was observed after replacement of the media. At 20 h after washout, bupivacaine and ropivacaine showed insignificant percentage growth cone collapse in comparison to their control values whereas those for lidocaine and mepivacaine were significantly higher than the control values. Larger concentrations of the nerve growth factor (NGF) did not improve this reversibility. In conclusion, local anesthetics produced morphological changes in growing neurons with significantly different IC50. The reversibility of these changes differed among the four drugs and was not influenced by the NGF concentration.
IMPLICATIONS: Local anesthetics induce growth cone collapse and neurite degeneration in the growing neurons. Mepivacaine was safer than lidocaine, bupivacaine, and ropivacaine for the primary cultured chick neurons.
This article has been cited by other articles:
![]() |
J.-W. Yi, B.-J. Lee, D.-O. Kim, S.-W. Park, Y.-K. Choi, H.-K. Chang, C.-J. Kim, and J.-H. Park Effects of bupivacaine and ropivacaine on field potential in rat hippocampal slices Br. J. Anaesth., May 1, 2009; 102(5): 673 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Luo, M. Yu, S. D. Smith, M. Kritzer, C. Du, Y. Ma, N. D. Volkow, P. S. Glass, and H. Benveniste The Effect of Intravenous Lidocaine on Brain Activation During Non-Noxious and Acute Noxious Stimulation of the Forepaw: A Functional Magnetic Resonance Imaging Study in the Rat Anesth. Analg., January 1, 2009; 108(1): 334 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Umbrain, L. Shi, M.-H. Lauwers, I. Smolders, Y. Michotte, and F. Camu Intrathecal lidocaine elevates prostaglandin E2 levels in cerebrospinal fluid: a microdialysis study in freely moving rats Br. J. Anaesth., November 1, 2008; 101(5): 716 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lirk, I. Haller, H. P. Colvin, L. Lang, B. Tomaselli, L. Klimaschewski, and P. Gerner In Vitro, Inhibition of Mitogen-Activated Protein Kinase Pathways Protects Against Bupivacaine- and Ropivacaine-Induced Neurotoxicity Anesth. Analg., May 1, 2008; 106(5): 1456 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lirk, I. Haller, H. P. Colvin, S. Frauscher, L. Kirchmair, P. Gerner, and L. Klimaschewski In Vitro, Lidocaine-Induced Axonal Injury Is Prevented by Peripheral Inhibition of the p38 Mitogen-Activated Protein Kinase, but Not by Inhibiting Caspase Activity Anesth. Analg., December 1, 2007; 105(6): 1657 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Rohm and J. Boldt Persisting Neurological Symptoms After Uncomplicated Intrathecal Bupivacaine Anesth. Analg., October 1, 2006; 103(4): 1047 - 1047. [Full Text] [PDF] |
||||
![]() |
C.J. Park, S.A. Park, T.G. Yoon, S.J. Lee, K.W. Yum, and H.J. Kim Bupivacaine Induces Apoptosis via ROS in the Schwann Cell Line Journal of Dental Research, September 1, 2005; 84(9): 852 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wiertlewski, A. Magot, S. Drapier, J.-M. Malinovsky, and Y. Pereon Worsening of Neurologic Symptoms After Epidural Anesthesia for Labor in a Guillain-Barre Patient Anesth. Analg., March 1, 2004; 98(3): 825 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saito, I. A. M. Radwan, K. Nishikawa, H. Obata, T. Okamoto, T. Kanno, and F. Goto Intracellular Calcium Increases in Growth Cones Exposed to Tetracaine Anesth. Analg., March 1, 2004; 98(3): 841 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. M. Radwan, S. Saito, and F. Goto Neurotrophic Factors Can Partially Reverse Morphological Changes Induced by Mepivacaine and Bupivacaine in Developing Sensory Neurons Anesth. Analg., August 1, 2003; 97(2): 506 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kasaba, S. Onizuka, and M. Takasaki Procaine and Mepivacaine Have Less Toxicity In Vitro Than Other Clinically Used Local Anesthetics Anesth. Analg., July 1, 2003; 97(1): 85 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Eisenach, T. L. Yaksh, P. Marhofer, and M. Semsroth Epidural Ketamine in Healthy Children--What's the Point? * Response Anesth. Analg., February 1, 2003; 96(2): 626 - 627. [Full Text] [PDF] |
||||
|